Literature DB >> 16623078

Sexual dysfunction in female hypertensives.

Basil N Okeahialam1, Ndudim C Obeka.   

Abstract

PURPOSE: Hypertension and its treatment are known to produce sexual dysfunction in males. In our culture, women are not free to discuss issues of sexuality with their doctors. Hence, this phenomenon has not been explored in them. Notwithstanding this, cases occur in practice where noncompliance with dire consequences result from sexual dysfunction. This study was done to determine if any dysfunction existed among women as is commonly reported in males.
METHODOLOGY: As part of a larger study on serum uric acid and lipid profile of adult Nigerian hypertensives, we sought information on sexual function in females. One group was newly diagnosed and treatment naïve, while the other was made up of known hypertensives on thiazides. The third group consisted of normotensive age-matched controls.
FINDINGS: Six out of 44 (13.6%) in the first group, five out of 29 (17.2%) in the second group and two out of 43 (4.7%) in the control group reported sexual dysfunction. The commonest aspect encountered was reduced desire for intercourse.
CONCLUSION: There was a tendency for hypertensive women to have more sexual dysfunction even before treatment than did controls. Larger studies should be undertaken and clinicians should probe this subject if poor compliance is suspected.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16623078      PMCID: PMC2569242     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  7 in total

Review 1.  Barriers to blood pressure control in African Americans. Overcoming obstacles is challenging, but target goals can be attained.

Authors:  Janice G Douglas; Keith C Ferdinand; George L Bakris; James R Sowers
Journal:  Postgrad Med       Date:  2002-10       Impact factor: 3.840

Review 2.  What is causing your patient's sexual dysfunction? Uncovering a connection with hypertension and antihypertensive therapy.

Authors:  M S Kochar; L I Mazur; A Patel
Journal:  Postgrad Med       Date:  1999-08       Impact factor: 3.840

3.  Sex, drugs, and hypertension: a methodological approach for studying a sensitive subject.

Authors:  L E Duncan; C Lewis; C E Smith; P Jenkins; M Nichols; T A Pearson
Journal:  Int J Impot Res       Date:  2001-02       Impact factor: 2.896

Review 4.  Prevalence and risk factors of sexual dysfunction in men and women.

Authors:  R C Rosen
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

Review 5.  Sexual function in women. Do antihypertensive drugs have an impact?

Authors:  L Duncan; D N Bateman
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

Review 6.  Sexual dysfunction with antihypertensive drugs.

Authors:  L M Prisant; A A Carr; P B Bottini; D S Solursh; L P Solursh
Journal:  Arch Intern Med       Date:  1994-04-11

Review 7.  Female sexuality.

Authors:  John E Morley; Fran E Kaiser
Journal:  Med Clin North Am       Date:  2003-09       Impact factor: 5.456

  7 in total
  6 in total

1.  Sexual Dysfunction in Women with Hypertension: a Systematic Review and Meta-analysis.

Authors:  Larissa Marques Santana; Lisiane Perin; Rosana Lunelli; José Francisco Secorun Inácio; Clarissa Garcia Rodrigues; Bruna Eibel; Silvia Goldmeier
Journal:  Curr Hypertens Rep       Date:  2019-04-03       Impact factor: 5.369

2.  High Prevalence of Sexual Dysfunction in a Vulvovaginal Specialty Clinic.

Authors:  Dina Gordon; Carolyn Gardella; David Eschenbach; Caroline M Mitchell
Journal:  J Low Genit Tract Dis       Date:  2016-01       Impact factor: 1.925

Review 3.  Management of Hypertension with Female Sexual Dysfunction.

Authors:  Qing Zhong; Yuri Anderson
Journal:  Medicina (Kaunas)       Date:  2022-05-05       Impact factor: 2.948

4.  Sexual activity and function among middle-aged and older men and women with hypertension.

Authors:  Erica S Spatz; Maureen E Canavan; Mayur M Desai; Harlan M Krumholz; Stacy T Lindau
Journal:  J Hypertens       Date:  2013-06       Impact factor: 4.844

5.  Sacubitril/Valsartan Improves Sexual Function and Fibrosis of the Clitoral and Vaginal Tissues in Female Spontaneously Hypertensive Rats.

Authors:  Chenchen Zhuang; Wenjuan Wang; Runmin Sun; Miaomiao Qi; Jing Yu
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

6.  Prevalence of Hypoactive Sexual Desire Disorder Among Sexually Active Postmenopausal Women With Metabolic Syndrome at a Public Hospital Clinic in Brazil: A Cross-sectional Study.

Authors:  Gustavo Maximiliano Dutra da Silva; Sônia Maria Rolim Rosa Lima; Benedito F Reis; Carolina Furtado Macruz; Sóstenes Postigo
Journal:  Sex Med       Date:  2020-06-24       Impact factor: 2.491

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.